featured
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: Heart Failure
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
JACC Heart Fail 2024 Aug 16;[EPub Ahead of Print], R Patel, M Wadid, B Makwana, A Kumar, S Khadke, A Bhatti, A Banker, Z Husami, S Labib, D Venesy, G Fonarow, M Kosiborod, S Al-Kindi, DL Bhatt, S Dani, A Nohria, J Butler, S GanatraFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.